Enhanced antigen-specific antibody and cytokine responses when targeting antigen to human FcGAMMA receptor type i using an anti-human FcGAMMA receptor type i-streptavidin fusion protein in an adjuvant-free system

Immunological Investigations

Volumn 34, Issue 4, 2005, Pages 417-429

  Adamova, Elisaveta ^a   Walsh, Mary C ^b   Gosselin, Diane R ^a   Hale, Karen ^a   Preissler, Mark T ^a   Graziano, Robert F ^c   Gosselin, Edmund J ^a  

^a ALBANY MEDICAL COLLEGE   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c MEDAREX INC   (United States)

Author keywords

Adjuvant; Fc receptor; Immune response; Streptavidin; Vaccine

Indexed keywords

FC GAMMA RECEPTOR 1 STREPTAVIDIN FUSION PROTEIN; FC RECEPTOR; HYBRID PROTEIN; RECOMBINANT VACCINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ANTIGEN EXPRESSION; ANTIGEN PRESENTING CELL; ANTIGEN SPECIFICITY; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; IMMUNIZATION; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN TARGETING; RECEPTOR BINDING; TH1 CELL; TH2 CELL;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIBODY FORMATION; ANTIGENS; CYTOKINES; HUMANS; IMMUNIZATION; IMMUNOGLOBULIN VARIABLE REGION; MALE; MICE; MICE, INBRED C57BL; RECEPTORS, IGG; RECOMBINANT FUSION PROTEINS; STREPTAVIDIN;

EID: 27644509821     PISSN: 08820139     EISSN: 15324311     Source Type: Journal    
DOI: 10.1080/08820130500265372     Document Type: Article

References (18)

1. Banchereau, J., Steinman, R. M. (1998). Dendritic cells and the control of immunity. Nature 392(6673):245-252.
2. Fanger, N. A., Voigtlaender, D., Liu, C., Swink, S., Wardwell, K., Fisher, J., Graziano, R. F., Pfefferkorn, L. C., Guyre, P. M. (1997). Characterization of expression, cytokine regulation, and effector function of the high affinity IgG receptor Fc gamma RI (CD64) expressed on human blood dendritic cells. J. Immunol. 158(7):3090-3098.
3. Gosselin, E. J., Wardwell, K., Gosselin, D. R., Alter, N., Fisher, J. L., Guyre, P. M. (1992). Enhanced antigen presentation using human Fc gamma receptor (monocyte/macrophage)-specific immunogens. J. Immunol. 149(11):3477-3481.
4. Guyre, P. M., Graziano, R. F., Vance, B. A., Morganelli, P. M., Fanger, M. W. (1989). Monoclonal antibodies that bind to distinct epitopes on Fc gamma RI are able to trigger receptor function. J. Immunol. 143(5):1650-1655.
5. Guyre, P. M., Graziano, R. F., Goldstein, J., Wallace, P. K., Morganelli, P. M., Wardwell, K., Howell, A. L. (1997). Increased potency of Fc-receptor-targeted antigens. Cancer Immunol. Immunother. 45(3-4):146-148.
6. Guyre, C. A., Keler, T., Swink, S. L., Vitale, L. A., Graziano, R. F., Fanger, M. W. (2001). Receptor modulation by Fc gamma RI-specific fusion proteins is dependent on receptor number and modified by IgG. J. Immunol. 167(11):6303-6311.
7. Heijnen, I. A., van Vugt, M., Fanger, N. A., Graziano, R. F., de Wit, T., Hofhuis, F. M., Guyre, P. M., Capel, P. J., Verbeek, J. S., van de Winkel, J. G. (1996). Antigen targeting to myeloid-specific human Fc gamma RI/CD64 triggers enhanced antibody responses in transgenic mice. J. Clin. Invest. 97(2):331-338.
8. Johnston, S. A., Barry, M. A. (1997). Genetic to genomic vaccination. Vaccine 15(8):808-809.
9. Keler, T., Guyre, P. M., Vitale, L. A., Sundarapandiyan, K., van de Winkel, J. G., Deo, Y. M., Graziano, R. F. (2000). Targeting weak antigens to CD64 elicits potent humoral responses in human CD64 transgenic mice. J. Immunol. 165(12):6738-6742.
10. Kyi, K. P., Oo, K. M., Htun, M. M., Tun, W. M., Aye, K. K., Oo, S. S., Lwin, K. O., Nyunt, S. (2002). Clinical trial of the intradermal administration of hepatitis B vaccine produced at the Department of Medical Research, Myanmar. Vaccine 20(11-12):1649-1652.
11. Liu, C., Goldstein, J., Graziano, R. F., He, J., O'Shea, J. K., Deo, Y., Guyre, P. M. (1996). F (c)gammaRI-targeted fusion proteins result in efficient presentation by human monocytes of antigenic and antagonist T cell epitopes. J. Clin. Invest. 98(9):2001-2007.
12. Morokata, T., Ishikawa, J., Yamada, T. (2000). Antigen dose defines T helper 1 and T helper 2 responses in the lungs of C57BL/6 and BALB/c mice independently of splenic responses. Immunol. Lett. 72(2):119-126.
13. Propst, T., Propst, A., Lhotta, K., Vogel, W., Konig, P. (1998). Reinforced intradermal hepatitis B vaccination in hemodialysis patients is superior in antibody response to intramuscular or subcutaneous vaccination. Am. J. Kidney Dis. 32(6):1041-1045.
14. Puri, N., Weyand, E. H., Abdel-Rahman, S. M., Sinko, P. J. (2000). An investigation of the intradermal route as an effective means of immunization for microparticulate vaccine delivery systems. Vaccine 18(23):2600-2612.
15. Sheikh, N. A., al-Shamisi, M., Morrow, W. J. (2000). Delivery systems for molecular vaccination. Curr. Opin. Mol. Ther. 2(1):37-54.
16. Steinman, R. M., Pope, M. (2002). Exploiting dendritic cells to improve vaccine efficacy. J. Clin. Invest. 109(12):1519-1526.
17. Stingl, G., Katz, S. I., Clement, L., Green, L., Shevach, E. M. (1978). Immunologic functions of Ia-bearing epidermal Langerhans cells. J. Immunol. 121(5):2005-2013.
18. Walsh, M. C., Banas, J. A., Mudzinski, S. P., Preissler, M. T., Graziano, R. F., Gosselin, E. J. (2003). A two-component modular approach for enhancing T-cell activation utilizing a unique anti-FcgammaRI-streptavidin construct and microspheres coated with biotinylated-antigen. Biomol. Eng. 20(1):21-33.